This guidance sets out the circumstances in which it may be appropriate to offer a course of prophylactic antiviral medicine to patients with a serious underlying medical condition or who are pregnant during the H1N1 (swine flu) pandemic.
Related articles
-
HSJ KnowledgePartnership working and the flu pandemic
The H1N1 pandemic never reached the intensity feared, but the emergency response set in place has strengthened partnership working.
-
NewsSwine flu vaccine bill cost department £239m
The government spent £239m on the swine flu vaccine, official figures reveal.
-
NewsRise in intensive care beds occupied by flu patients
The number of flu cases being treated in critical care beds has increased by 66 per cent in the last week, according to figures released by the Department of Health.
More from News
-
HSJ AwardsHSJ Awards 2025: Partnership of the Year
WINNER Lilly UK & Dementias Platform UK and The Trials Delivery Framework, in collaboration with Greater Manchester MHFT, Oxford Health FT, University Hospitals Sussex FT and Sheffield Teaching Hospital FT Improving accurate, early diagnosis of Alzheimer’s Disease using cerebral spinal fluid testing
-
HSJ AwardsHSJ Awards 2025: Independent Healthcare Provider of the Year
WINNER Inhealthcare and Leeds Teaching Hospitals Reducing bed days through virtual wards
-
HSJ AwardsHSJ Awards 2025: Workforce Initiative of the Year
WINNERNHSE - One NHS FinanceNHS Finance Insights Placement Scheme
No comments yet